Having largely recovered from the impact of the global financial crisis and with several impressive fundamentals in…

Save Share

Following on from Johnson & Johnson’s acquisition of Actelion in January 2017 and Takeda’s takeover of…

Save Share

China’s regulator approved a biosimilar version of Roche’s Rituxan this week, the first such drug ever to be…

Save Share

Already established as one of the world’s leading markets for innovative and patented drugs, Japan is set to grow…

Save Share

Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare…

Save Share

This is the first in a series of articles examining what it takes to be a country manager of a multinational pharma…

Save Share

Roche announced strong Group sales growth of seven percent for 2018, partly driven by the launch of MS blockbuster…

Save Share

Across the month of January, we at PharmaBoardroom surveyed our executive readership on attitudes towards the…

Save Share

Click here to download the Healthcare & Life Sciences Review Algeria 2019 report. Algeria, Africa’s…

Save Share

Basel-headquartered pharma giant Novartis announced its financial results for 2018 this week, showcasing full year…

Save Share

After 61 years of single-party rule, the May 2018 electoral victory of the populist Pakatan Harapan (PH) coalition…

Save Share

In late 2018 China adopted a novel procurement scheme with the aim of dramatically cutting the amount being paid…

Save Share